Skip to main content
Fig. 2 | Stem Cell Research & Therapy

Fig. 2

From: Human umbilical cord-derived mesenchymal stem cells not only ameliorate blood glucose but also protect vascular endothelium from diabetic damage through a paracrine mechanism mediated by MAPK/ERK signaling

Fig. 2

The body weight (A), fasting blood glucose (FBG) (B), and blood levels of VCAM-1 (C) and ICAM-1 (D) in the control (n = 8), model (n = 8), MSC-L (n = 8) and MSC-H (n = 8) groups. The data at 0 week was obtained before hucMSCs treatment, and the data at 1, 2, 3, 4 week were obtained 7 days after each hucMSCs treatment. Data were mean ± SD. *P < 0.05 and **P < 0.01 versus the control group, #P < 0.05 and ##P < 0.01 versus the model group

Back to article page